Effect of aspirin on all-cause mortality in the healthy elderly
Background: In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically high...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Massachusetts Medical Society
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/74680 |